YAP promotes erlotinib resistance in human non-small cell lung cancer cells

Yes-associated protein (YAP) is a main mediator of the Hippo pathway, which promotes cancer development. Here we show that YAP promotes resistance to erlotinib in human non-small cell lung cancer (NSCLC) cells. We found that forced YAP overexpression through YAP plasmid transfection promotes erlotin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ping-Chih, You, Bin, Yang, Yi-Lin, Zhang, Wen-Qian, Wang, Yu-Cheng, Xu, Zhidong, Dai, Yuyuan, Liu, Shu, Yang, Cheng-Ta, Li, Hui, Hu, Bin, Jablons, David M., You, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239524/
https://www.ncbi.nlm.nih.gov/pubmed/27409162
http://dx.doi.org/10.18632/oncotarget.10458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239524/
https://www.ncbi.nlm.nih.gov/pubmed/27409162
http://dx.doi.org/10.18632/oncotarget.10458

Ejemplares similares